deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02596126

Secondary Prevention of Cardiovascular Disease in the Elderly Trial (SECURE)

Sponsor: Centre Hospitalier Universitaire de Besancon

Conditions Cardiovascular Disease Myocardial Infarction
Interventions Cardiovascular Polypill Treatment Prevention for Secondary CV
Updated 14 times since 2017 Last updated: May 22, 2025 Started: Jul 31, 2016 Primary completion: Oct 31, 2021 Completion: Mar 31, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Cardiovascular Disease and Myocardial Infarction, this trial is completed. The trial is conducted by Centre Hospitalier Universitaire de Besancon and has accumulated 14 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2018 · 13 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Sep 2019 · 14 months · monthly snapshot~Sep 2019 – ~Jan 2021 · 16 months · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Jul 2022 · 9 months · monthly snapshot~Jul 2022 – ~Nov 2022 · 4 months · monthly snapshot~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshot~Jun 2025 – ~Sep 2025 · 3 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Jun 2025 — Sep 2025 [monthly]

    Completed PHASE3

  3. Sep 2024 — Jun 2025 [monthly]

    Completed PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  5. Nov 2022 — Jul 2024 [monthly]

    Completed PHASE3

▶ Show 9 earlier versions

  1. Jul 2022 — Nov 2022 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  2. Oct 2021 — Jul 2022 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  3. Jan 2021 — Oct 2021 [monthly]

    Recruiting PHASE3

  4. Sep 2019 — Jan 2021 [monthly]

    Recruiting PHASE3

  5. Jul 2018 — Sep 2019 [monthly]

    Recruiting PHASE3

  6. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE3

  7. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE3

  8. Feb 2017 — Mar 2018 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  9. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Hospitalier Universitaire de Besancon
  • Charite University, Berlin, Germany
  • Ferrer Internacional S.A.
  • Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
  • General University Hospital, Prague
  • Istituto Di Ricerche Farmacologiche Mario Negri
  • London School of Hygiene and Tropical Medicine
  • Semmelweis University
  • Servicio Madrileño de Salud, Madrid, Spain
  • Wroclaw Medical University
Data source: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

A Coruña, Spain , Alba, Italy , Alcalá de Henares, Spain , Alicante, Spain , Angermünde, Germany , Angers, France , Barcelona, Spain , Benešov, Czechia , Berlin, Germany , Bernau, Germany and 77 more locations